Induction of unstable and stable chromosomal aberrations by 99mtc: in-vitro and in-vivo studies

Nuclear Medicine Communications

Volumn 26, Issue 10, 2005, Pages 913-918

  Guiraud Vitaux, Françoise ^a   Jacquet, Nelly ^b   Petiet, Anne ^b   Roy, Laurence ^b   Voisin, Philippe ^b   Colas Linhart, Nicole ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Institute of Radiobiological Protection and Nuclear Safety   (France)

Author keywords

Biological dosimetry; Bone scintigraphy; Technetium 99m; Translocation; Unstable chromosome aberration

Indexed keywords

OXIDRONATE TECHNETIUM TC 99M; TECHNESCAN;

ADULT; ARTICLE; BONE SCINTISCANNING; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DICENTRIC CHROMOSOME; DOSE RESPONSE; FLUORESCENCE IN SITU HYBRIDIZATION; GIEMSA STAIN; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE; PERIPHERAL LYMPHOCYTE; POISSON DISTRIBUTION; RADIATION DOSE; RECIPROCAL CHROMOSOME TRANSLOCATION; RING CHROMOSOME; SCORING SYSTEM;

ADULT; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; RADIATION DOSAGE; RADIATION INJURIES; RADIOPHARMACEUTICALS; RISK ASSESSMENT; RISK FACTORS; TECHNETIUM;

EID: 26444477599     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200510000-00010     Document Type: Article

References (36)

1. International Atomic Energy Agency. Biological dosimetry: chromosomal aberration analysis for dose assessment. Technical Report series no. 260, 1986.
2. Bender MA, Awa AA, Brooks AL, Evans HJ, Groer PG, Littlefield LG, et al. Current status of cytogenetic procedures to detect and quantify previous exposures to radiation. Mutat Res 1988; 196:103-159.
3. Doloy MT, Malarbet JL, Guedeney G, Bourguignon M, Leroy A, Reillaudou M, et al. Use of unstable chromosome aberrations for biological dosimetry after the first post-irradiation mitosis. Radiat Res 1991; 125:141-151.
4. DuFrain RJ, Littlefield LG, Joiner EE, Frome EL. In vitro human dose-response systems. In: Hübner KF, Fry SA (editors): The Medical Basis for Radiation Accident Preparedness. North Holland: Elsevier; 1980, pp. 357-374.
5. Baugnet-Mahieu L, Lemaire M, Léonard ED, Léonard A, Gerber GB. Chromosome aberrations after treatment with radioactive iodine for thyroid cancer. Radiat Res 1994; 140:429-431.
6. M'Kacher R, Legal JD, Schlumberger M, Voisin P, Aubert B, Gaillard N, et al. Biological dosimetry in patients treated with 131 radioiodine for differentiated thyroid carcinoma. J Nucl Med 1996; 37:1860-1864.
7. M'Kacher R, Legal JD, Schlumberger M, Aubert B, Beron-Gaillard N, Gaussen A, et al. Sequential biological dosimetry after a single treatment with iodine-131 for differentiated thyroid carcinoma. J Nucl Med 1997; 38:377-380.
8. M'Kacher R, Schlumberger M, Legal JD, Violot D, Beron-Gaillard N, Gaussen A. Biologic dosimetry in thyroid cancer patients after repeated treatments with iodine-131. J Nucl Med 1998; 39:825-829.
9. 131I-Lipiodol therapy in patients with hepatocellular carcinoma. J Nucl Med 2004; 45:612-618.
10. Bachand M, Seifert AM, Messing K. Nuclear medicine patients do not have higher mutant frequencies after exposure. Mutat Res 1991; 262:1-6.
11. Kelsey KT, Donohoe KJ, Memisoglu A, Baxter B, Caggana M, Liber HL. In vivo exposure of human lymphocytes to technetium-99-m in nuclear medicine patients does not induce detectable genetic effects. Mutat Res 1991; 264:213-218.
12. Seifert AM, Bradley WEC, Messing K. Exposure of nuclear medicine patients to ionizing radiation is associated with rises in HPRT mutant frequencies in peripheral T-lymphocytes. Mutat Res 1987; 191:57-63.
13. Robinson M, Colas-Linhart N, Guiraud-Vitaux F, Petiet A, Bok B. Heterogeneous distribution of technetium-99-m labeled microspheres in rat lungs: microautoradiographic evidence and dosimetric consequences. J Nucl Med 1997; 38:650-654.
14. Jacquet N, Bourahla K, Guiraud-Vitaux F, Petiet A, Voisin P, Colas-Linhart N. Biological consequences of irradiation by low doses of technetium-99m: ultrastructural studies, p53 protein expression and cytogenetic effects. Cell Mol Biol 1999; 45:1139-1147.
15. Bauchinger M. Retrospective dose reconstruction of human radiation exposure by FISH/chromosome painting. Mutat Res 1998; 404:89-96.
16. Finnon P, Lloyd DC, Edwards AA. Fluorescence in situ hybridization detection of chromosomal aberration in human lymphocytes: applicability to biological dosimetry. Int J Radiat Biol 1995; 65:429-435.
17. Roy L, Sorokine-Durm I, Voisin P. Comparison between fluorescence in situ hybridization and conventional cytogenetics for dicentrics scoring: a first-step validation for the use of FISH in biological dosimetry. Int J Radiat Biol 1996; 70:665-669.
18. Lloyd DC, Edwards AA. Chromosome aberrations in human lymphocytes: effect of radiation quality, dose and dose rate. In: Ishihara T, Sasaki MS (editors): Radiation-induced Damage in Man. New York: Alan R. Liss; 1983, pp. 23-49.
19. 99mTc: evaluation of dose and chromosome aberrations in irradiated lymphocytes. Cell Mol Biol 2001; 47:545-548.
20. Sorokine-Durm I, Durand V, Delbos M, Le Baron L, Roy L, Voisin P. A French view on FISH painting as a biodosemeter. Radiat Prot Dosim 2000; 88:35-44.
21. Tucker JD, Morgan WF, Awa AA, Bauchinger M, Blakey D, Conforth MN, et al. A proposed system for scoring structural aberrations detected by chromosome painting. Cytogenet Cell Genet 1995; 68:211-221.
22. Morton NE. Parameters of the human genome. Proc Natl Acad Sci USA 1991; 88:7474-7476.
23. Sorokine-Durm I, Durand V, Le Roy A, Paillole N, Roy L, Voisin P. Is FISH an appropriate biological marker for dose estimates of suspected accidental radiation overexposure? A review of cases investigated in France from 1995 to 1996. Environ Health Perspectives 1997; 105:1427-1432.
24. Lucas JN, Awa A, Straume T, Poggensee M, Kodama Y, Nakano M, et al. Rapid translocation frequency analysis in humans decades after exposure to ionizing radiations. Int J Radiat Biol 1992; 62:53-63.
25. Lloyd DC, Edwards AA, Prosser JS, Corp MJ. The dose response relationship obtained at constant irradiation times for the induction by chromosome aberrations in human lymphocytes by cobalt-60 gamma rays. Radiat Environ Biophys 1994; 23:179-189.
26. Ramalho AT, Curado MP, Natarajan AT. Lifespan of human lymphocytes estimated during a 6 years cytogenetic follow-up of individuals accidentally exposed in the 1987 radiological accident in Brazil. Mutat Res 1995; 331:47-54.
27. Edwards A, Voisin P, Sorokine-Durm I, Maznik N, Vinnikov V, Mikhalevich L, et al. Biological estimates of dose to inhabitants of Belarus and Ukraine following the Chernobyl accident. Radiat Prot Dosim 2004; 111:211-219.
28. Tawn EJ, Whitehouse CA, Tarone RE. FISH chromosome aberration analysis on retired radiation workers from the Sellafied nuclear facility. Radiat Res 2004; 192:249-256.
29. Preston J. Biological dosimetry: mechanistic concepts. In: Empresa Nacional de Residnos Radioactivos, Madrid, Spain (editors): I Reunion Internacional sobre dosimetria biologica. 1990, pp. 21-34.
30. Ramsey MJ, Moore DH, Briner JF, Lee DA, Olsen LA, Senft JR, Tucket JD. The effects of age and lifestyle factors on the accumulation of cytogenetic damage as measured by chromosome painting. Mutat Res 1995; 338:95-106.
31. Schwochau K. Technetium radiopharmaceuticals - Fundamentals, synthesis, structure and development. Angew Chem Ed Engl 1994; 33:2258-2267.
32. Giver CR, Moore DH, Pallavicini MG. Radiation-induced translocations in mice: persistence, chromosome specificity, and influence of genetic background. Radiat Res 2000; 154:283-292.
33. Natarajan AT, Santos SJ, Darroudi F, Hadjidikova V, Vermeulen S, Chatterjee S, Berg M, et al. 137 Cesium-induced chromosome aberrations analysed by fluorescence in situ hybridization: eight years follow up of the Goiânia radiation accident victims. Mutat Res 1998; 400:299-312.
34. Hagmar L, Bonassi S, Strönberg U, Brogger A, Knudsen H, Norppa H, et al. Chromosomal aberrations in lymphocytes predict human cancer. A report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res 1998; 58:4117-4121.
35. Ballarini F, Ottolenghi A. A model of chromosome aberration induction and chronic myeloid leukaemia incidence at low doses. Radiat Environ Biophys 2004; 43:165-171.
36. Feinendegen EL, Pollycove M. Biologic responses to low doses of ionizing radiation: detriments versus hormesis. Part 1. Dose responses of cells and tissues. J Nucl Med 2001; 42:17N-27N.